top of page

Funding

We have listed below some of the key funding calls (mainly grants) that are applicable to companies in UK healthcare. For more information, please contact us.

Upcoming Funding Calls
BridgeAI Supply Chain Demonstrator

Funder: Innovate UK

Opens: 24 June 2024

Closes: 11am 21 August 2024

Sectors: Logistics & transport, agriculture & food processing, construction

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

These projects will be to accelerate the development and adoption of artificial intelligence solutions across supply chains of the UK economy. The projects are intended to benefit efficiency in supply chains and improve business decisions at firm level. Your project’s total grant funding request must be between £1.9 million and £2 million.
 

The aim of this competition is to develop a product or process that enables data from micro, small and medium sized enterprises (SMEs) and large organisations to be shared in a trust less environment. The product or process must enable the development of new Artificial Intelligence solutions for the benefit of supply chain efficiency and firm level productivity. The output of these projects must be in the form of a demonstrator.
 

 

Your project must demonstrate clear monetisation strategies that incentivize data sharing and business models that span benefits across organisations and sectors.
More information.

Current Funding Calls
Enhancing biomedical and health-related data and digital platform resources

Funders: Medical Research Council, NIHR

Open: 9 April 2024

Closes: 4pm 18 June 2024 

Sector: Health & life sciences

Apply for data and digital platform resources that will support, manage, link, share and access data at scale for biomedical, health and care research within the remit of MRC, NIHR or both. Maximum award £3,750,000 (out of a total fund of £15 million)

Applications should be for work that includes:

  • enhancing platforms, environments and their operations

  • capabilities for users, for example data ingress or egress tools, analytics

  • mechanisms to manage findable, accessible, interoperable, reusable (FAIR Principles) data

  • technical approaches to managing interface between secure health and social care data and biomedical research data

  • unique linkage of health and related datasets, for example research generated data, environmental, administrative, and wearable data.

Applicants should be a researcher or specialist employed by an eligible research organisation. This includes eligible individuals with roles or job titles such as Research Software Engineer.

The duration of awards is up to five years. The full economic cost (FEC) of your project can be up to £3,750,000. MRC and NIHR will fund 80% of the FEC.

More information.

New Innovators in digital technology, North East England

Funders: Innovate UK/ North East LEP/ North of Tyne Combined Authority

Opened: 7 May 2024 

Closes: 11am 19 June 2024 

Sector: All, including health

The project’s total costs and grant funding request must be between £25,000 and £50,000 and must last for 3-6 months (ending by 31 March 2025). If your business has been funded directly by Innovate UK previously, you are not eligible to be offered funding through this competition. An eligible UK business can submit one application only. 

Your project must use the funding to help grow your innovation activities in the digital technology cluster in North East England, both during and after the project.

 

For this competition, North East England consists of Northumberland, Tyne and Wear, and County Durham.


Your innovation can lead to new products, processes or services that are significantly ahead of others currently available, or propose an innovative use of existing products, processes or services. It can also involve a new or innovative business model.

More information here.

New Innovators in life and health sciences, Northern Ireland

Funders: Innovate UK/ Invest Northern Ireland 

Opened: 7 May 2024

Closes: 11am 19 June 2024 

Sector: Health & life sciences

The project’s total costs and grant funding request must be between £25,000 and £50,000 and it must last 3-6 months, ending no later than 31 March 2025. If your business has been funded directly by Innovate UK previously, you are not eligible to be offered funding through this competition. Only one application per SME.
 

The project can focus on one or more of the following (not an exhaustive list):

  • diagnostics

  • therapeutics

  • biomarkers

  • data, digital and medical devices, including for healthcare delivery planning

  • technologies that support the supply chain for life and health sciences.

More information here.

NIHR Incubator competition 2024

Funder: NIHR

Opened: 20 March 2024

Closes: 1pm 20 June 2024

Sector: Healthcare & Life sciences

NIHR Incubators offer the opportunity to delve into the complex issues and barriers that exist in capacity building in a particular area by the community who are embedded in and who have forged careers in these areas. The funding enables a community to bring together key stakeholders to suggest and implement solutions to building research capacity and developing research careers in a sustainable and meaningful way. Their focus will be on building academic research capacity in terms of attracting and retaining people in the area of interest, but there should be consideration of a broad spectrum of research careers.

 

NIHR particularly encourages applications for Incubators that focus on the following areas/disciplines (please see the guidance notes for further information):

  • Knowledge Mobilisation Research

  • General Paediatrics and moving research across the age range

Please note, only the top-ranked application will be funded in each of the highlight notice areas. Applicants are asked not to propose an Incubator in areas/disciplines where there is currently an NIHR-supported Incubator. A list of the 10 current Incubators can be found here.

NIHR Incubators are for a 3 year period and will receive:

  • NIHR badging and support for 3 years, including the opportunity for all Incubator Leads to meet regularly

  • £30,000 funding per annum (over the 3 year Incubator period) to cover some or all of the cost of a project manager/admin support post

  • £10,000 per annum (over the 3 year Incubator period) for additional engagement activities

Register to attend the 2024 NIHR Incubator Competition Webinar on Wednesday 8th May 2024 (11.30 - 12.30).

Guidance notes.

Cancer Innovation Award Scheme

Funder: West Yorkshire and Harrogate Cancer Alliance

Open: 1 May 2024

Closes: 5pm 21 June 2024

Sector: Health and Life sciences

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

The Innovation Award Scheme is a non-recurrent, revenue-only, financial awards scheme which seeks to:

  • Promote innovation in cancer care

  • Encourage the adoption, acceleration, and deployment of best practice

  • Support the strategic objectives of the Cancer Alliance

  • Ensure that available cancer transformation funding responds to needs identified locally, as well as those taken from policy priorities nationally

  • Create opportunities to improve early diagnosis and patient experience in line with the NHS Long Term Plan  
     

This year the Awards have two schemes:

  • Scheme 1 includes reserved funding allocation for Trust, Place, and the VCSE (Voluntary, Community and Social Enterprise) sector

  • Scheme 2 is a new competitive funding element, available to any partner eligible for funding under Scheme 1

More information.

Future Leaders Fellowships: round 9, business and non-academic

Funder: UKRI

Opened: 7 March 2024

Closes: 11am 25 June 2024

Sector: All

UK registered organisations can apply for a share of up to £110 million for ambitious research and innovation projects in any sector, and tailored support to develop careers for future leaders.

The aim of this competition is to:

  • support ambitious research and innovation to tackle difficult and novel challenges

  • support excellence in innovation, across interdisciplinary boundaries and sectors

  • develop, retain, and attract the next wave of research and innovation leaders

Working with a host organisation a Future Leaders Fellow will receive at least four years of funding to pursue an ambitious programme of innovation. The fellow will also have access to tailored opportunities and resources to develop their career as a future leader in their field. The Future Leaders Fellowships programme is open to all early-career innovators and researchers.
 

Your project’s total grant funding request must be between £300,000 and £3 million.

Eligibility criteria.

Knowledge transfer partnerships (KTP): 2024 to 2025 Round 2

Funder: Innovate UK

Opened: 15 April 2024

Closes: 11am 26 June 2024 

Sector: All

Led by an UK higher education (HE) or further education (FE) institution, research and technology organisation (RTO) or Catapult., your application must be for a specific, strategic innovation project that tackles one or more challenges faced by the business partner.

It can be any kind of project and must show:

  • why the business needs this Knowledge Transfer Partnership (KTP)

  • what new knowledge is required by the business

  • what new capabilities will be embedded as a result of the KTP.

Typically, a project’s total costs are £8,500 per month. Projects must be between 12 and 36 months. A proportion of the knowledge base partners’ costs will be funded by Innovate UK. The remainder of the project costs are paid by the business partner.

More information here.

Research Programme for Social Care (RPSC)

Funder: NIHR/ HTA

Opened: 6 March 2024

Closes: 26 June 2024

Sector: Healthcare/ Social Care

The aim of RPSC is to fund research that generates evidence to increase the effectiveness of social care services, provides value for money and benefits people who need or use social care services, and carers. Research will cover both adults and children's social care.
 

RPSC welcomes high-quality proposals from researchers and practitioners that are focused on but not limited to:

  • Studies of social care needs, circumstances and relevant outcomes related to adults, children or young people who need or use social care and carers, including studies of inequalities in any of these domains

  • Evaluation of existing or new social care services, addressing their effectiveness, cost-effectiveness and distributional consequences

  • Effectiveness and cost-effectiveness evaluations of interventions, including adaptations or refinements of existing interventions/technologies

  • Developing and testing new assessments, interventions or services

  • Research methods development

  • Feasibility, pilot and definitive trials

  • Research examining consequences for social care users of provision of other services (e.g., health, education, criminal justice, family courts, housing, benefits)

  • Policy-implementation research

  • Studies that involve secondary data analysis or record linkage

  • Systematic or other reviews of evidence

  • Strategies for preventing or delaying the need for care and support

  • Research on approaches to support and strengthen the social care workforce

  • Capacity-building opportunities within awards

 

The Programme does not have a budget limit for individual projects. Teams need to propose a budget that is appropriate for the proposed work packages, project duration, resources, public involvement, equality, diversity and inclusion strategy, and collaborations. Please note that value for money will still be one of the key criteria of assessment.” The total programme fund is £10m.

 

The NIHR RPSC team are hosting a webinar for RPSC Call 2 at 10am to 12pm on 04 April 2024. You can register here.

More information.

Advancing Healthcare Small Grants

Funder: Barts Charity

Open

Closes: 27 June 2024

Advancing Healthcare Small Grants provide funding of up to £50,000 for NHS staff to pilot new ideas, technologies and ways of working within Barts Health NHS Trust that could advance healthcare delivery and improve the health of its local community. At least one applicant must be employed by Barts for the duration of the proposed work. This grant can be applied for 4 times a year. Duration of funding - 18 months.

More information.

Sector: Healthcare

NIHR Research for Patient Benefit programme (Competition 54)

Funder: NIHR

Opened: 13 March 2024

Closes: 1pm 10 July 2024

Sector: Healthcare & Life sciences

The NIHR Research for Patient Benefit (RfPB) programme is inviting stage 1 applications for research proposals that are concerned with the day-to-day practice of health service staff, and that have the potential to have an impact on the health or wellbeing of patients and users of the NHS.

As a researcher-led programme, RfPB does not specify topics for research but instead encourages proposals for projects that address a wide range of health service issues and challenges.

The funding available for individual projects is up to £500,000 for up to 36 months. Feasibility studies are expected to cost less than £300,000 (Tier 2), and proposals that will generate results that might be useful for more downstream investigations are expected to cost less than £200,000 (Tier 3). RfPB has a two stage application process.

More information.

Funder: Innovate UK

Opened: 13 May 2024

Closes: 11am 10 July 2024

Sector: All

Women within UK registered micro, small and medium-sized enterprises (SMEs) can apply for a share of up to £4 million to develop their exciting and innovative ideas. The £75,000 grant also includes bespoke business support. This competition is open to single applicants only.

 

To lead a project you must be a woman founder, co-founder or senior decision maker within a UK registered SME that has been registered on Companies House for at least 12 months.

More information.

Funding for early stage development of new healthcare interventions

Funder: MRC

Opened: 10 May 2024

Closes: 4pm 10 July 2024

Sector: Health & Life sciences

Apply for MRC funding (£50,000 to £300,000) to the Developmental Pathway Gap Fund (DPGF), to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development. The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product. The Gap fund sits beyond the smaller and shorter Impact Accelerator funding and before the substantive and longer Developmental Pathway Funding Scheme.

You can apply for academically led translational projects that aim to undertake a focused package of work that will bridge the gap between inception of a new idea and substantive funding through schemes such as the MRC Developmental Pathway Funding Scheme to:

  • help prevent disease

  • help improve speed and accuracy of diagnosis of disease

  • develop new treatments of disease

  • help to improve outcome monitoring of patients receiving treatment

  • help to improve the management of diseases and conditions
     

Your project should have already explored a new concept and generated some data in support of the approach. This fund will provide small scale funding to generate critical data needed prior to seeking more substantive funding. A non-exhaustive list of examples of the types of projects that could be supported include:

  • elements of therapeutic discovery, quantification, and validation

  • development of an initial prototype

  • early prototype testing

  • initial biomarker validation

  • vector identification or optimisation

  • hit expansion medicinal chemistry
     

All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues. The principal investigator (PI) must be based at the lead organisation, which should be one of the following six types of organisation.

  • Higher education institutions

  • Independent research organisations (IROs) and NHS bodies

  • Public Sector Research Establishments

  • MRC institutes (MRC Harwell, MRC London Institute of Medical Sciences and MRC Laboratory of Molecular Biology)

  • MRC units and partnership Institutes

  • Institutes and units funded by other research councils

More information

New Innovators in health technologies, West Yorkshire

Funders: Innovate UK, West Yorkshire Combined Authority

Opened: 10 June 2024

Closes: 11am 17 July 2024

Sector: Healthcare

The aim of this competition is to provide a package of targeted support to enable ambitious UK registered micro and small businesses to develop highly innovative ideas that have a clear route to commercialisation and business growth. A project’s total costs and grant funding request must be between £25,000 and £50,000 and last between three and six months. 

Your project must focus on health technology innovation, which could address any human health challenges:

  • overcoming health inequalities

  • global net zero challenges in healthcare

  • major health conditions

  • the prevention of disease

  • earlier and better detection and diagnosis of disease

  • other challenges that can be tackled with health technologies

More information here.

UK-Taiwan CRD 2024

Funder: Innovate UK

Opened: 08 April 2024

Closes: 17 July 2024

Sectors: Biotech, Green energy, AI, smart manufacturing

The aim of this competition is to fund business led, collaborative research and development (CR&D) projects focused on industrial research, for innovative proposals developed between the UK and Taiwan. 

UK registered businesses can apply for a share of up to £5 million (maximum £900,000 each) for the purpose of developing innovative proposals with Taiwan. You must collaborate with at least one Taiwan business applying under the equivalent DoIT programme.

The projects Innovate UK fund are expected to result in a new product, industrial process or service, be innovative, involve a technological risk, and have high market potential.

It would particularly welcome applications from the following sectors:

 

  • smart technology, for example next generation communication, semiconductor technology and space technology

  • green energy technologies, for example electric vehicles, hydrogen transportation, renewable energy, future grids and carbon capture utilisation and storage

  • smart manufacturing

  • biotechnology, for example medical materials and devices

  • service innovation, for example the Internet of Things, Big Data, Artificial Intelligence, 5G and 6G

More information.

Funder: MRC

Open: 5 June 2024

Closes: 4pm 17 July 2024

Sector: Health & Life sciences

Apply for MRC’s funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be based at a UK research organisation (includes NHS bodies) eligible for UKRI funding. You can apply for academically-led translational projects that aim to either:

  • improve prevention, diagnosis, prognosis or treatment of significant health needs

  • develop research tools that increase the efficiency of developing interventions

Project should focus on at least one of the following stages of development:

  • early development and design

  • pre-clinical testing

  • early-phase clinical studies and trials (up to phase 2a).

There’s no limit on the amount of funding you can apply for, typically fund 80% of the full economic cost. 

More information.

Digital technology enabled interventions in Social Care

Funder: HTA/ NIHR

Opened: 22 March 2024

Closes: 1pm 24 July 2024

Sector: Social care

This Programme is accepting Stage 1 applications to their commissioned workstream for this research topic. Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a Stage 2 application. Applicants will have 8 weeks to complete and submit their Stage 2 application form.

This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study.

Thee is a webinar to discuss the HTA Programme's current funding opportunities in social care on 21 May 2024, 12pm to 1.15pm. Applicants may register to attend just the webinar by emailing their name and institution to htaresearchers@nihr.ac.uk 

The HTA Programme is interested in proposals for the evaluation of a wide range of digital technologies for social care across both children and adult services, including, but not limited to:

  • digital applications for promoting behaviour change to prevent deterioration of a specific long-term condition or improve general wellbeing

  • technologies designed to improve the personal safety and/or well-being of people who draw on care and support services and carers, e.g. technologies aimed at preventing falls or alerting carers to a fall, geographical positioning systems (GPS), home monitoring systems

  • digital memory aids, e.g. technologies to support the following advice or guidance from health and social care practitioners and/or organising social care related aspects of their lives

  • digital interventions for loneliness or social isolation

  • remote assessments (or other care planning processes) (child development, occupational, etc.)

  • enablers of the adoption of digital technologies by citizens and their support networks, such as tools aimed at improving digital literacy and preventing digital exclusion among specific populations

  • robotics for assisting simple tasks such as cognitive assistive robots, socially assistive robots

Digital technologies include a broad range of both hardware and electronic devices, such as smart watches; software, such as mobile applications, and internet delivered services such as online support groups

 

Applicants should clearly define and justify the specific population of interest, study design and outcome measures. In defining these, they should ensure a strong emphasis on social care outcomes, as well as appropriate balance between considerations primarily affecting the users of assistive technologies (including people with lived experience and their support networks) such as ease of use, psychosocial wellbeing or requirements around privacy, and the implementation and economic factors of concern to local authorities and other social care organisations.

Other commissioning information.

Innovate UK Smart grants

Funder: Innovate UK

Opened: 25 April 2024

Closes: 11am 24 July 2024 

Sector: All

UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable R&D innovations that can significantly impact the UK economy. Applications can come from any area of technology and be applied to any part of the economy.
 

Projects of 6 to 18 months must have total eligible project costs between £100,000 and £500,000 and can be single or collaborative.   Projects of 19 to 24 months must have total eligible project costs between £100,000 and £1 million and be collaborative.   
Eligibility criteria.

ABOVE (Arise Beyond Open Innovation for Value and Entrepreneurship)

Funders: Medilink Midlands, Anglia Ruskin University, and Essex County Council

Open

Closes: Ongoing until August 2024 (rolling applications)

Sector: Healthcare in Essex, UK

‘Arise Beyond Open Innovation for Value and Entrepreneurship’ (ABOVE) is a new collaborative programme delivered in partnership with Arise Innovation Hubs, part of Anglia Ruskin University. The ABOVE programme will provide innovation support grants as well as sector-specific events around the themes of health, performance and wellbeing. As a specialist provider of support to the life science sector,

Medilink Midlands continue to partner with Arise Innovation Hubs to provide expert guidance to SMEs on how to overcome barriers to growth throughout their innovation journey. Essex County Council has provided the funding for this project in support of their ten-year strategy to grow the life science, DigiTech, advanced manufacturing and engineering sectors, leading to more opportunity, jobs and growth across Essex.
 

Alongside an ongoing support and events programme, the ABOVE programme will provide a limited number of innovation grants. Essex SME’s can apply for up to £5,000 to help unlock their business potential.
More information

Efficacy studies seeking to improve the health and wellbeing of women (24/50)

Funder: NIHR/ MRC

Opened: 21 May 2024

Closes: 1pm 20 August 2024

Sector: Health& Life sciences

The MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme is inviting applications for efficacy trials that aim to improve the health and wellbeing of women. This could include, but is not limited to, trials investigating conditions that only affect women, or conditions that affect both men and women but may affect women either disproportionately or in a different way. It does not include maternity disparities - see NIHR Challenge – Maternity Inequalities.

There is no set upper limit for the duration or cost of applications, however value for money will be a key consideration.

All proposals submitted must describe an evaluation of an intervention or technology, which falls within the scope of the EME Programme. Applications are expected to detail the clinical need, scientific rationale and proof of concept for the intervention, as well as how the study has the potential to improve women's health. Applicants are encouraged to consider opportunities to embed the testing of mechanistic hypotheses within the main study, where
relevant.

Applications are particularly encouraged in the following areas:

  • Areas of research within which women have been historically under-represented.

  • Topics that are under-represented in the EME and HTA portfolios. Applicants can undertake searches of the funded portfolio on the NIHR Funding and Awards website.

  • Hypothesis-testing mechanistic studies to examine a differential response to a treatment between men and women (“mechanism of action” research). This may be embedded within an efficacy study, or make use of patients or samples from an existing NIHR study or other completed study, with the same eligibility criteria as a mechanistic study application to the current EME Researcher-Led funding opportunity.

  • Rare diseases that affect women.
     

More information

Clinical Study Grants

Funder: British Heart Foundation

Open

Closes: 5pm 29 August 2024

Sector: Healthcare

The Clinical Study Grant supports funding for over £350,000 for:

  • Interventional clinical trials: trials of specific interventions or pathways of care for the prevention, diagnosis and treatment of cardiovascular disease. Interventions include drugs, surgery, devices, psychological, physical and educational interventions.

  • Observational studies of specific patient groups that are hypothesis led and address a defined clinical question(s) over a fixed timescale (up to 5 years). The population of interest should be a patient population, who will usually be recruited within the NHS. The study should have a predefined outcome(s) that will lead to changes in clinical management directly or will inform the development of a clinical trial to test an intervention.

  • Clinical studies can include a mechanistic evaluation, either as a sub-study within a clinical trial or as part of an observational study.

More information.​

Eurostars Funding

Funder: Horizon - European Union

Open: 

Closes: 12 September 2024

Sector: All

Innovative SMEs in any of the 37 participating countries can bid for up to €360,000 per project. Approximately 29% of all bids are likely to be successful. Innovate UK covers up to 60% of project costs in grants for SMEs. Innovate UK will not fund large companies, universities or research organisations as part of this grant. 

To apply, you must fulfill seven eligibility criteria:

  • The project consortium is led by an innovative SME from a Eurostars country.

  • The project consortium is composed of at least two entities that are independent from one another.

  • The project consortium is composed of entities from at least two participating countries with a minimum of one organisation from an EU or Horizon Europe Associated Country.

  • The budget of the SMEs from the participating countries (excluding any subcontracting) is 50% or more of the total project cost.

  • No single participant or country is responsible for more than 70% of the budget of the project.

  • The project duration is 36 months or less.

  • The project has an exclusive focus on civil applications.

 

Innovate UK has additional national criteria for projects to be eligible to receive funding - see here for details.

Applications can be made here.

Accessible and Affordable Tests for Early Detection of Heritable Cancers in European Regions

Funder: European Commission

Opened: 18 April 2024

Closes: 18 September 2024

Sector: Healthcare

A single stage funding call, part of the Horizon Europe programme. 

Expected EU Contribution per Project -between €10 million and €12 million out of a total indicative budget of €35 million.

Proposals should aim to deliver results through validating, piloting, and upscaling genetic, multi-omics, or other biomarker-based tests for early detection of cancers with underlying heritable genetic risk in routine healthcare. There are six topics included in the call:

  • Improve understanding of the development of cancer in the context of the environment, work, and lifestyle in the broadest possible sense,

  • Enhance cross-policy cancer prevention strategies,

  • Optimise the diagnostics and treatment of cancer based on the principle of equitable access,

  • Improve the quality of life of cancer patients, survivors and their families through widely analysing all key factors and needs that are related to the quality of life,

  • Accelerate the digital transformation of research, innovation and health systems.

The work to be funded will include:

  • Conducting clinical and socio-economic feasibility studies.

  • Co-creating testing protocols and procedures with end-users, including healthcare professionals and citizens.

  • Extensively piloting and upscaling testing in at least 3 different EU Member States or Associated Countries, with a focus on Eastern Europe.

  • Collaborate with EIT-Health KIC networks for support in entrepreneurship, education, and innovation.

More information

Novel and Emerging Technologies (NET) Grants

Funder: Heart Research UK

Open

Closes: 2 October 2024

Sector: Healthcare

This unique grant  (limit of £300,000) gives researchers the opportunity to apply for funding to develop a novel and emerging technology or a new application of an existing technology.

NET grants are research projects which focus on the development of new and innovative technologies to diagnose, treat and prevent heart disease and related conditions.

Research projects with the emphasis on (1) novel and emerging technologies and (2) their application into cardiovascular disease prevention and/or treatment, which can be expected to benefit patients within a foreseeable timeframe, will be considered.

Appropriate approaches include tissue and bioengineering, the development and evaluation of new diagnostic devices, bio imaging, nanotechnology, biomaterials, genomic, and proteomic approaches, computational biology and bioinformatics.

Funding clinical trials through the NET Grant scheme is not appropriate. However, research projects incorporating a small scale clinical study to demonstrate the feasibility of the technology will be considered, providing that the clinical study is not the main focus of the research programme. Projects that are more specifically clinically focused should be directed to the Translational Research Project (TRP) grants scheme.

For example, the grant may support emerging strategies/ technologies in the management of risk factors, the evaluation of invasive cardiology procedures (eg angioplasty and stent replacement), and evaluation of new surgical approaches to cardiovascular disease, strategies aimed at improving the efficacy of ventricle assist and other devices, and the outcomes of resuscitation after cardiac arrest.

A multidisciplinary approach is encouraged. Proposals should be based on excellent science and also clearly describe the future clinical implications and the translational strategy.

More information.

EIC Accelerator

Funder: Horizon Europe

Opens: 14 March 2024

Closes: 3 October 2024

Sector: All technology sectors

The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:

  • have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide,

  • have the ambition and commitment to scale up,

  • are looking for substantial funding, but the risks involved are too high for private investors alone to invest

Applications consist of:

  • A 5-page form where you must summarise your proposal and respond to a set of questions on your innovation, your potential market and your team;

  • A pitch-deck of up to ten slides in pdf format;

  • A video pitch of up to three minutes where the core members of your team (up to three people) should provide the motivation for your proposal.

Applicants will normally receive feedback within 4 weeks.

More information.

Canada-UK: Biomanufacturing of Biologics and Advanced Therapies Round 2

Funders: Innovate UK, National Research Council of Canada Industrial Research Assistance Program

Opened: 8 May 2024

Closes: 11am 16 October 2024

Sector: Healthcare & Life sciences

UK registered organisations can apply for a share of up to £3 million for collaboration with Canadian SMEs on joint R&D projects, for enabling technologies and innovations in biomanufacturing of biologics and advanced therapies.

 

The aim of this competition is to stimulate the development and implementation of innovative technologies in biomanufacturing. The objective is to build the desired flexibility and technical capabilities required for the development and economically sustainable production of the next generation vaccines and therapies.

The total grant funding request for all UK partners can be up to £600,000 for each application. The total funding request for all Canadian partners combined can be up to CA$1 million for each application.

More information.

Advancing Healthcare Small Grants

Funder: Barts Charity

Open

Closes: 17 October 2024

Advancing Healthcare Small Grants provide funding of up to £50,000 for NHS staff to pilot new ideas, technologies and ways of working within Barts Health NHS Trust that could advance healthcare delivery and improve the health of its local community. At least one applicant must be employed by Barts for the duration of the proposed work. This grant can be applied for 4 times a year. Duration of funding - 18 months.

More information.

Sector: Healthcare

Clinical Study Grants

Funder: British Heart Foundation

Open

Closes: 5pm 23 October 2024

Sector: Healthcare

The Clinical Study Grant supports funding for over £350,000 for:

  • Interventional clinical trials: trials of specific interventions or pathways of care for the prevention, diagnosis and treatment of cardiovascular disease. Interventions include drugs, surgery, devices, psychological, physical and educational interventions.

  • Observational studies of specific patient groups that are hypothesis led and address a defined clinical question(s) over a fixed timescale (up to 5 years). The population of interest should be a patient population, who will usually be recruited within the NHS. The study should have a predefined outcome(s) that will lead to changes in clinical management directly or will inform the development of a clinical trial to test an intervention.

  • Clinical studies can include a mechanistic evaluation, either as a sub-study within a clinical trial or as part of an observational study.

More information.​

SMART: SCOTLAND

Funder: Scottish Enterprise

Opens: 09 November 2023

Closes: 09 November 2024

Sector: All

SMART:SCOTLAND is a research and development (R&D) grant for small and medium-sized businesses that aims to support high risk, highly ambitious projects. It covers conducting feasibility studies to show how ideas could work in the real world and supports activities that have a commercial endpoint. The grant is only available to small and medium enterprises (SMEs) based in Scotland and supports the activities of commercially focused R&D projects.

The grant can support up to 70% of the eligible costs for a small enterprise and up to 60% of the eligible costs for a medium enterprise. Studies must last between 6 and 18 months, and the maximum grant is £100,000.

More information.

Smart Flexible Innovation Support (FIS)

Funder: The Welsh Government

Opens: 15 June 2023

Closes: 09 November 2024

Sector: All

The Welsh Government is investing £30 million in new programmes that will help Welsh organisations develop and embed new innovative products and services to help improve people’s lives, grow the economy and address the climate and nature emergency.

SMART FIS is not restricted to businesses and research organisations.  It is open to any organisation wishing to engage in research, development and innovation (RD&I), including the third sector, local authorities and health boards.

For a new organisation this might mean accessing technology to get a new idea off the ground; for a developing one, it could be help with a project which you know has potential; and for an established organisation it might be about specialist know-how to give you an international edge by opening up new markets.

Funding is dependent on the organisation and type of project. A typical example would be £100,000 per year for 2 years.

More information.

Implementation research for management of multiple long-term conditions in the context of non-communicable diseases

Funder: European Commission

Opened: 25 April 2024 

Closes: 5pm (CET) 26 November 2024

Sector: Healthcare

It is expected that 5 grants will be awarded of €3m - €4m each.

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:

  • Health care practitioners and providers in low- and middle-income countries (LMICs) and/or those in high-income countries (HICs) serving disadvantaged populations have access to and use specific guidelines to implement health interventions that improve the availability of effective, equitable, efficient, integrated, patient-centred, safe, and timely care and the overall quality of life for people living with multiple long-term conditions including non-communicable diseases (NCDs).

  • Public health managers and authorities, including from other relevant sector (e. g., social, culture) have access to improved insights and evidence on how to decrease the fragmentation of care for patients living with multiple chronic conditions, and ensure continuity of care across all stages of disease progression. They use this knowledge to design policies to reduce health inequities.

  • Adopting an implementation science approach to studying interventions for management of multiple long-term conditions in the context of NCDs, researchers, clinicians and authorities have an improved understanding how the proposed interventions could be adopted in LMICs and/or disadvantaged populations of HICs setting, taking into account specific social, political, economic and cultural contexts.

  • Communities and local stakeholders and authorities are fully engaged in implementing and taking up interventions for management of multiple long-term conditions in the context of NCDs and thus contribute to deliver better health.
     

The following types of projects will NOT be funded:
i) proposals focused on primary prevention of NCDs or other chronic conditions;
ii) proposals with the primary aim of informing the development and/or selection of an intervention for a given context, where the implementation component will be explored in a future project;
iii) epidemiological cohorts;
iv) etiological work, mechanistic, or epidemiological research, unless an essential component of a focused study to develop implementation research approaches;
v) clinical trials, validation studies, or intervention efficacy studies for a new or established pharmacological agent or behavioural intervention.

More information.

Tackling obesity

Funder: MRC

Open

Closes: No closing date

Sector: Healthcare & Life sciences

Apply for funding to develop effective strategies to tackle overweight and obesity.

‘Tackling obesity’ is open to applications submitted to the Population and Systems Medicine Board.

The MRC is seeking multidisciplinary and interdisciplinary applications to tackle overweight and obesity. The research should support evidence-based approaches to improve health in real-life settings. In particular, the MRC wishes to better understand what makes an effective intervention. This is by encouraging greater integration and synergy across existing pockets of expertise in the biological, behavioural, psychological, environmental and social sciences.

You should apply through the existing funding opportunity most relevant to your science area and career stage. There is no limit to the funding you can apply for, but it should be appropriate to the research project. We will usually fund up to 80% of your project’s full economic cost. This is an ongoing funding priority for the Population and Systems Medicine Board. Application rounds close every January, May and September.

More information.

Global Innovation Fund- Grants

Funder: Global Innovation Fund

Open, no closing date

Sector: All

The Global Innovation Fund is a non-profit, impact-first investment fund headquartered in London with offices in Washington, D.C. and Nairobi. It invests in the development, rigorous testing, and scaling up of new products, services, business process, or policy reforms that are more cost-effective than current practice and targeted at improving the lives of the world's poorest people.

It accepts applications from organisations working in any sector in any developing country. Any type of organisation may apply. This includes social enterprises, for-profit companies, non-profit organisations, government agencies, international organisations, and research institutions in any country. It is recommended that individual innovators, entrepreneurs, or researchers apply through an affiliated organisation. 

More information.

Catapult/RTO Grants

Funder: Innovate UK Business Growth

Open, no closing date

Sector: All

Up to £15,000 grants available for:

  • Sector specific advice on expertise;

  • Testing and/or development work;

  • Market analysis, cost modelling etc;

  • Identifying opportunities for R&D, partnership building & collaboration, and more.

More information.​

Past Funding Calls
Advancing Healthcare Large Grants

Funder: Barts Charity

Open

Closed: 06 June 2024

Sector: Healthcare

The Advancing Healthcare Large Grants provide funding (£50,000 to £500,000) for NHS staff to pilot new ideas, technologies and ways of working within Barts Health NHS Trust that could advance healthcare delivery and improve the health of its local community. At least one applicant must be employed by Barts for the duration of the proposed work.
Duration of funding - up to 36 months.

More information.

NHS Cancer Programme Innovation Open Call 3

Funder: SBRI Healthcare

Opened: 8th April 2024
Closed: 1pm 29 May 2024

Sector: Healthcare/ Life Sciences

Applications are invited for innovations or new approaches that will detect cancers earlier and increase the proportion diagnosed at stage one or two.


The competition aims to fast-track high quality, proven, late-stage innovations into front-line settings, as well as address implementation evidence gaps. Innovations will be 100% funded up to the total value of £4 million (excluding VAT) over a maximum of 24 months.
More information.

Invention for Innovation - Product Development Awards Call 28

Funder: NIHR

Opened: 10 April 202

Closed: 1pm, 29 May 2024

Sector: Healthcare & Life Sciences

The i4i Product Development Awards (PDA) supports collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care systems. PDA are researcher-led and aim to de-risk innovations, supporting early product development and real-world evaluation, to make them more attractive for follow-on funding and further commercial investment. The expected focus of a PDA project is to: 

  • carry out product development required to enable technologies for clinical use or use in social care, 

  • carry out the clinical development of a laboratory-validated technology, and/or 

  • accelerate the development and uptake of innovative products, which already have demonstrated safety and efficacy.


The aim is to accelerate benefits to patients and end users, de-risk the technologies and make them attractive to follow-on funders, investors and buyers, in particular NHS commissioners and national guidance bodies. Projects must have demonstrated proof-of-concept as a minimum, which is generally described as TRL3. A minimum of two organisations must be involved.

More information.

Transforming Prediction and Early Diagnosis in the Community

Funder: Engineering and Physical Sciences Research Council

Opened: 19 March 2024 

Closed:4pm 29 May 2024

Sector: Healthcare

Apply for funding to develop novel tools and technologies for patient-specific prediction, early and accurate diagnosis of physical and mental health conditions for use in the community.

Projects should engage relevant partners to ensure the research is co-created and co-delivered. Projects should contribute to tackling health inequalities and embed equitable, diverse, and inclusive patient and public involvement and engagement (PPIE).

The full economic cost (FEC) of your project can be up to £2,500,000. EPSRC will fund 80% of the FEC (up to £2,000,000). Projects can be up to 36 months.

More information

NIHR Challenge: Maternity Inequalities

Funder: NIHR

Opened: 13 March 2024

Closed: 22 May 2024

Sector: Healthcare

Funding: £50 million

The first ever NIHR Challenge funding call, backed by £50 million, will task researchers and policymakers with finding new ways to tackle maternity disparities.

This funding call will bring together a diverse consortium, funding research and capacity building. The aim is to increase the evidence base to address maternity inequalities, facilitating a multidisciplinary whole systems approach to address uncertainties across research, innovation and implementation.

The stage 1 process will invite organisations to apply to join the consortium. Successful organisations will come together at stage 2 to develop the work programme including large scale ambitious projects which lead to a step change and measurable improvement in maternity inequalities. Selected organisations forming the consortium will also be expected to draw in wider expertise, such as practitioners, charities, industry, implementation, and systems experts to ensure geographical spread and that research is undertaken where the need is greatest.

More information.

Programme Development Grants - Competition 39

Funder: NIHR

Opened: 27 March 2024

Closed: 1pm 22 May 2024

Sector: Healthcare

Programme Development Grants are available for researchers to undertake preparatory work to develop a future programme of research (Stream A).

PDGs are also available for researchers to develop and enhance the quality and value of an ongoing or recently completed Programme Grants for Applied Research (PGfAR) award (Stream B)

 

NIHR PDG and the Royal College of Paediatrics and Child Health (RCPCH) highlight for child health and wellbeing research (Stream B)

The scope of the call includes but is not limited to safeguarding, disability/neuro-disability, community child health and care, mental health in children and young people, health inequalities, social care and public health issues, and obesity. In recognition that significant development work will be required to formulate a competitive programme of applied research, development awards will first be made available via the NIHR Programme Development Grants programme (Stream A only) to enable national multi sector and multi-professional research teams to be formed and/or existing teams to be consolidated and strengthened, and to undertake preparatory research work.

Applications to the PDG RCPCH Stream A highlight notice can be for up to £250,000 and over a period of 12 to 18 months.

More information

Women Tech EU project

Funder: Horizon Europe/ EU

Opened: 18 March 2024

Closed: 5pm (CET) 20 May 2024

Sector: All

The overarching goal of Women Tech EU is to support women founders and entrepreneurs leading deep tech start-ups from Europe to grow into tomorrow’s tech leaders and to put women at the forefront of deep tech in Europe.

The first open call will select and empower 40 women-led deep tech early-stage start-ups that will contribute to the green, digital and social transition in line with the European objectives.

The call is open to women entrepreneurs from all over the European Union and Horizon Europe associated countries who meet the eligibility criteria described in the call documents. With €75,000 funding (non-diluting finance) and a six month personalised business development programme, the project will be paving the way for these innovators to shine as leaders in deep tech innovation across Europe.

Eligibility Criteria

  • Applicants must be established in an EU Member State or a Horizon Europe Associated Country, with the company registered for at least six months at the time of submission.

  • The start-up must be in the early-stage, defined as not more than 8 years old and having raised less than €1 million in equity funding.

  • Women must be legally recognized as founders or co-founders and hold a top management position (CEO, CTO, or equivalent), with at least 25% of the company's shares.

  • Projects should focus on deep tech innovations offering solutions to societal problems across various sectors.

More information and to apply.

Ready2Scale Accelerator

Funder: European Union

Opened: 15 March 2024

Closed:15 May 2024

Sector: Digital and deep tech

The Ready2Scale Acceleration Programme is an all-encompassing 6-month journey tailored to substantially boost the growth of 25 chosen digital and deep tech startups. There is a Grant Award per Project of up to €60,000 + mentorship, networking and investment opportunities. 

Eligible startups may receive up to €60,000 in grant funding, allocated across travel expenses up to €5,000, expert consultations up to €5,000, and up to €50,000 for product development.

 Startups should be involved in the digital and deep tech sectors with at least one full-time employee. Preference is given to startups previously supported by the EIC or those with private/EU funding. 

The first cohort will support 15 startups (June 2024), and the second cohort will support 10 (January 2025), aiming to provide comprehensive financial and developmental assistance to a total of 25 startups.

More information.

Innovate UK investor partnerships

Funder: Innovate UK

Open: 15 April 2024

Closed:  11am 15 May 2024

Sector: All sectors

Investors can apply to partner with Innovate UK to invest in innovative SMEs aligned with grant funding.

However, there is no Innovate UK funding awarded to applicant investors. Grant funding will be awarded by Innovate UK to applicant companies (SMEs) to cover a proportion of eligible project costs alongside your aligned investment from or led by one or more investor partners. The investment will typically be in the form of equity but can include other forms of funding, such as convertible loans.

Innovate UK currently has 115 investor partners, who are described in a directory on its 
website. It is seeking additional investor partners to join this programme for the future through this investor selection process.

Potential SME applicants will be able to apply for grant funding for:

 

  • feasibility studies, which can have eligible project costs from £50,000 to £300,000, can last between 6 and 12 months and will have grants of up to 70%, with at least the same amount of aligned investment from or led by an investor partner

  • industrial research projects, which can have eligible project costs from £100,000 to £1 million, can last between 6 and 15 months and will have grants of up to 70%, with at least the same amount of aligned investment from or led by an investor partner

  • experimental development projects, which can have eligible project costs from £250,000 to £2 million, can last between 12 and 15 months and will have grants of up to 45% for micro and small businesses or up to 35% for medium sized businesses, with at least twice the amount of aligned investment from or led by an investor partner

The investor partnership programme will cover specific themes within the future economy, as described in Innovate UK’s plan for action, in particular:

 

  • net zero

  • health and wellbeing

  • next generation digital technologies and technology families

More information here.

Launchpad grant for Mental Health

Funder: Medical Research Foundation

Open

Closed: 12pm, 8 May 2024

Sector: Healthcare

The Medical Research Foundation is inviting mid-career researchers in the field of mental health to apply for up to £100,000 to support their research.

 

Funded research should increase understanding of mental health, and improve diagnosis, treatment and recovery. It will also act as a launchpad for further research suitable for larger funding opportunities.

 

Applications within a broad field of mental health research are welcomed. However, applications are encouraged from neglected areas of mental health, including suicide and self-harm, trauma-related mental health, borderline personality disorder and OCD. Neurodevelopmental disorders are considered within the scope of this competition, and especially encouraged are applications from researchers working in ADHD and Tourette’s.

 

Applicants to the Launchpad Grants in Mental Health can use the funding to conduct pilot studies, generate data and collaborations, and develop competitive research proposals for larger funding. The research should have a UK focus.

 

Applicants may apply for up to £100,000 to support their research, over a maximum of a 2-year period (pro-rata for part-time positions). This competition is open to all UK-based (mid-career) researchers and clinical academics at eligible institutions (UK HEIs, Research Council research institutes, hospitals, and other independent research organisations).

Applicants must hold a PhD, DPhil, MD or doctorate in a relevant area and be conducting their research at an eligible institution. Partnerships outside of academia are allowed, providing the collaboration will advance the research project in line with the aims of the funding call.

More information.

Diet and health innovation: early stage feasibility projects

Funders: Innovate UK, Biotechnology and Biological Sciences Research Council

Opened: 14 February 2024

Closed: 11am, 8 May 2024

Sector: Healthcare

UK registered organisations can apply for a share of up to £2.5 million for early stage feasibility projects working with one or more of the Diet and Health Open Innovation Research Club hubs. This funding is from BBSRC and Innovate UK.

The aim of this competition is to support UK registered businesses and UK research organisations in the design and development of innovative food products to support sustained health and wellbeing. Projects can be focussed across the life course and are not restricted to older populations.

 

Your proposal must have the potential to impact the nutritional quality of food and drink products consumed by the UK population.

Your project must:

  • have total costs between £100,000 and £250,000

  • last between 9 and 18 months

  • carry out all of its project work in the UK

  • intend to exploit the results from or in the UK

  • start by 1 October 2024

  • end by 31 March 2026

To lead a project your organisation must be a business of any size or a research organisation eligible for UK Research and Innovation (UKRI) funding. Your consortium must include at least one business and one research organisation, as a minimum.

Eligibility criteria.

Advancing Healthcare Small Grants

Funder: Barts Charity

Open
Closed: 02 May 2024

Advancing Healthcare Small Grants provide funding of up to £50,000 for NHS staff to pilot new ideas, technologies and ways of working within Barts Health NHS Trust that could advance healthcare delivery and improve the health of its local community. At least one applicant must be employed by Barts for the duration of the proposed work. This grant can be applied for 4 times a year. Duration of funding - 18 months.

More information.

Sector: Healthcare

UK-Switzerland CR&D Round 2 Funding Competition

Funders: Innovate UK, Innosuisse (The Swiss Innovation Authority)

Opened: 5 February 2024
Closed: 1 May 2024

Sector: Life sciences, AI, Semi conductors, Quantum

The aim of this competition is to enhance UK and Swiss collaborations and capabilities in the emerging fields of technology. The result being, the developing and delivering of new innovations and applications of the technologies across a broad range of other sectors.

 

The total grants includes up to £4 million from Innovate UK and a minimum of 3 million CHF from Innosuisse. UK projects can request grant funding of no more than £450,000. 

The bidding party must include a consortium of non-linked Swiss and UK partners. The projects must involve at least one Swiss implementation partner under the equivalent Swiss Innosuisse programme.

Eligibility criteria